Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series)

Increasingly, new technologies are making it possible to carefully identify sets of patients who are most likely to respond to a new drug. And the advances in the field are producing some startling data on the effectiveness of a new generation of therapeutics. If you're interested in biomarkers and translational medicine, you won't want to miss our upcoming webinar. March 23, 2pm ET/ 11am PT Register Now!